CHROMCHENKOVA, E.P.,
BOKOV, D.O.,
BESSONOV, V.V.,
SAMYLINA, I.A.,
KAKHRAMANOVA, S.D.,
CHEVIDAEV, V.V.,
SOKHIN, D.M.,
BALOBANOVA, N.P.,
EVGRAFOV, A.A.,
KRASNYUK, J.I.,
KUDASHKINA, N.V.,
GALIAKHMETOVA, E.K.,
MARAKHOVA, A.I.,
MOISEEV, D.V. (2020) a significant amount of arginine, studies involving the prevention and adjunctive treatment of
viralНЕВРОЛОГИЧЕСКИЕ И ПСИХИЧЕСКИЕ РАССТРОЙСТВА, АССОЦИИРОВАННЫЕ С COVID-19НОВИКОВА, Л.Б.,
АКОПЯН, А.П.,
ШАРАПОВА, К.М.,
ЛАТЫПОВА, Р.Ф.,
NOVIKOVA L.B.,
AKOPIAN A.P.,
SHARAPOVA K.M.,
LATYPOVA R.F. (2020) ,4 % patients with COVID-19. Currently, severe
viral hemorrhagic encephalitis, toxic encephalopathy, acute
Baltina, L.A.,
Hour, M.-J.,
Liu, Y.-C.,
Chang, Y.-S.,
Huang, S.-H.,
Lai, H.-C.,
Kondratenko, R.M.,
Petrova, S.F.,
Yunusov, M.S.,
Lin, C.-W. (2021) assays on the cytopathic effect (CPE) and
viral infectivity of ZIKV in three different human cell lines
Конъюктивит COVID-19 с осложненным течением. Случай из практикиBabushkin, Alexander E.,
Matyukhina, Ekaterina N.,
Saitova, Gulnaz R.,
Israfilova, Gulnara Z.,
Бабушкин, А.Э.,
Матюхина, Е.Н.,
Саитова, Г.Р.,
Исрафилова, Г.З. (2023) A clinical case of
viral conjunctivitis COVID-19, which was complicated by partial symblepharon